跳至主要内容
临床试验/NCT02103530
NCT02103530
已完成
不适用

Early Response Assessment of Induction Chemotherapy in Acute Myeloid Leukemia Patients Using F-18 FLT PET/CT

The Catholic University of Korea1 个研究点 分布在 1 个国家目标入组 10 人2014年4月

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Acute Myeloid Leukemia
发起方
The Catholic University of Korea
入组人数
10
试验地点
1
主要终点
Value of FLT PET/CT in early response assessment of induction chemotherapy in acute myeloid leukemia
状态
已完成
最后更新
10年前

概览

简要总结

The purpose of this study is to investigate whether F-18 FLT PET/CT is useful in early response assessment of induction chemotherapy in acute myeloid leukemia patients.

详细描述

Assessment of treatment response in AML is very important to determine the next treatment. Standard treatment of AML begins with induction chemotherapy. NCCN guideline recommend to assess the treatment response via bone marrow examination approximately 7-10 days after completion of induction chemotherapy. However, the possibility of sampling error and risks of infection and bleeding are the limitation of bone marrow biopsy. F-18 fluorodeoxythymidine (FLT) is a radiopharmaceutical for PET, reflecting the proliferation of the cell. F-18 FLT is trapped after phosphorylation by thymidine kinase1, whose expression is increased in replicating cells. There have been several studies that reported F-18 FLT PET could measure health and proliferation of the bone marrow. The aim of this study is to evaluate if F-18 FLT PET/CT is suitable for early response assessment of induction chemotherapy in acute myeloid leukemia patients.

注册库
clinicaltrials.gov
开始日期
2014年4月
结束日期
2015年12月
最后更新
10年前
研究类型
Interventional
研究设计
Single Group
性别
All

研究者

责任方
Principal Investigator
主要研究者

Woo Hee Choi, MD

Clinical assistant professor

The Catholic University of Korea

入排标准

入选标准

  • acute myeloid leukemia
  • must receive induction chemotherapy
  • 19 years old and over

排除标准

  • no standard therapy
  • pregnancy

结局指标

主要结局

Value of FLT PET/CT in early response assessment of induction chemotherapy in acute myeloid leukemia

时间窗: 4-6 wks after completion of induction chemotherapy

Correlation between the FLT PET/CT findings on day 8-12 after start of treatment with the result of bone marrow biopsy which is done 4-6 wks after completion of induction chemotherapy

研究点 (1)

Loading locations...

相似试验